If you require further searching capabilities for announcements please email: data@nzx.com

Ryman finalises repayment of debt facilities

27/03/2025, 11:41 NZDT, GENERAL

Ryman finalises repayment of debt facilities following equity raise Ryman Healthcare Limited (Ryman) (NZX: RYM) advises that it has finalised repayment arrangements with lenders following its approximately $1 billion equity raise which was completed on 17 March 2025. As part of these arrangements, Ryman has reached an agreement with lenders to repay its $275 million1 Institutional Term Loan (ITL) which was established in 2021. Ryman will repay the ITL in full, with costs for make-whole, prepayment fees and close out of the associated interest rate swap amounting to an additional $22 million2. An updated maturity profile for continuing debt facilities of $2,208 million3 following the repayments is set out in the Appendix to this announcement. ENDS Authorised by: Morgan Powell General Counsel About Ryman: Ryman Healthcare was founded in Christchurch in 1984 and owns and operates 49 retirement villages in New Zealand and Australia. Ryman villages are home to 15,300 residents, and the company employs 7,700 staff. Contacts: For investor relations information contact Hayden Strickett, Head of Investor Relations, on +64 27 303 1132 or hayden.strickett@rymanhealthcare.com For media information contact Camille Middleditch on +64 28 422 3472 or camille.middleditch@rymanexternal.com Currency: Unless otherwise stated, all references to “$” are to the New Zealand dollar (NZD). Australian dollar (AUD) amounts are presented in NZD using an NZD/AUD rate of 0.91 at 27 March 2025. Footnotes: 1: Reflects A$250 million facility translated to NZD. 2: Consistent with 24 February 2025 investor presentation, which disclosed potential costs of up to $35 million for make-whole and prepayment fees and close-out of AUD interest rate swap associated with the ITL. 3: Investor presentation dated 24 February 2025 disclosed pro-forma (unaudited) net debt post offer at 30 September 2024 of $1,587 million, which excluded costs associated with debt repayment following completion of the offer.